Optimization criteria for ordering myeloid neoplasm next‐generation sequencing
Approximately one third (59/174) of MN-NGS test orders can be safely canceled using these criteria, which would result in $150,370 of Centers for Medicare and Medicaid Services-reimbursed savings annually.
Authors
- Henry M. Rinder (ORCID: https://orcid.org/0000-0001-7271-7447)
- Alexa J. Siddon (ORCID: https://orcid.org/0000-0002-2372-3653)
- Karl Hager
- Christopher A. Tormey (ORCID: https://orcid.org/0000-0003-1785-2245)
- Savanah D. Gisriel (ORCID: https://orcid.org/0000-0002-3728-5826)
- Richard Torres (ORCID: https://orcid.org/0000-0003-0994-3980)
- John G. Howe
Institutions
- Yale University (US)
Publication Details
- Journal
- eJHaem
- Published
- 2024-10-23
- DOI
- https://doi.org/10.1002/jha2.1036
- Primary Topic
- Acute Myeloid Leukemia Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00